Private Equity Financings
As a result of signficant upfront expenditures on research & development, the most important source of capital for companies in the life science sector is venture capital financings. Related to its dedicated life science presence, Johnston Blakely has developed extensive relationships within the venture community. Our intimate knowledge of the life science financing environment coupled with our insight into individual venture investors' investment preferences allows the firm to assemble a compelling offering memorandum, initiate marketing, negotiate and close venture financings in an expeditious manner.

Non-Equity Growth Capital
Johnston Blakely is quite involved with other businesses active in the life science sectors, such as pharmaceutical service companies.  These companies' financial profile afford them access to additional financing instruments including senior and mezzanine debt. Accordingly, the firm also maintains the capability to execute debt financings for its clients with banks and finance companies with specialized life science lending practices.